Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge
Authors:
- Ivan P. NascimentoINIvan P. Nascimento
- Waldely O. DiasWDWaldely O. Dias
- Wagner QuintilioWQWagner Quintilio
- Ana P. ChristACAna P. Christ
- Josefina F. MoraesJMJosefina F. Moraes
- Mary D.C. VancettoMVMary D.C. Vancetto
- Gabriela Ribeiro-Dos-SantosGRGabriela Ribeiro-Dos-Santos
- Isaias RawIRIsaias Raw
- Luciana C.C. LeiteLLLuciana C.C. Leite
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 10 (2) , 198-202
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- What is new in pertussis?European Journal of Pediatrics, 2007
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005
- Pertussis vaccination strategies for neonates—an exploratory cost-effectiveness analysisVaccine, 2004
- Influence of Mycobacterium bovis Bacillus Calmette-Guérin on Antibody and Cytokine Responses to Human Neonatal VaccinationThe Journal of Immunology, 2002
- Immunity toMicrobes and Infection, 2001
- Recombinant BCG vaccinesVaccine, 2001
- Neonatal and early life vaccinologyVaccine, 2001
- T-cell function in newborn mice and humansImmunology Today, 1999
- Overview of Recent Clinical Trials of Acellular Pertussis VaccinesBiologicals, 1999
- Mutants of Pertussis Toxin Suitable for Vaccine DevelopmentScience, 1989